SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-22-027192
Filing Date
2022-05-16
Accepted
2022-05-16 16:45:54
Documents
66
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0322_aikidopharma.htm   iXBRL 10-Q 558419
2 CERTIFICATION f10q0322ex31-1_aikidopharma.htm EX-31.1 9542
3 CERTIFICATION f10q0322ex32-1_aikidopharma.htm EX-32.1 3932
  Complete submission text file 0001213900-22-027192.txt   3897688

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE aiki-20220331.xsd EX-101.SCH 60459
5 XBRL CALCULATION FILE aiki-20220331_cal.xml EX-101.CAL 30463
6 XBRL DEFINITION FILE aiki-20220331_def.xml EX-101.DEF 222597
7 XBRL LABEL FILE aiki-20220331_lab.xml EX-101.LAB 440325
8 XBRL PRESENTATION FILE aiki-20220331_pre.xml EX-101.PRE 238910
60 EXTRACTED XBRL INSTANCE DOCUMENT f10q0322_aikidopharma_htm.xml XML 393811
Mailing Address ONE ROCKEFELLER PLAZA, 11TH FLOOR NEW YORK NY 10020
Business Address ONE ROCKEFELLER PLAZA, 11TH FLOOR NEW YORK NY 10020 347-321-7646
AIkido Pharma Inc. (Filer) CIK: 0000012239 (see all company filings)

IRS No.: 520849320 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-05576 | Film No.: 22930256
SIC: 8731 Services-Commercial Physical & Biological Research